StockVS

The Joint Corp. (JYNT) Stock Analysis

Healthcare

The Joint Corp.

$9.22

+$0.27 (+3.02%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

The Joint Corp. functions as both a franchisor and an operator of chiropractic clinics across the United States, delivering services that encompass the training of franchisees and staff, site selection, construction, vendor management, and ongoing operational support. Operating within the Healthcare sector and specifically the Medical Care Facilities industry, the company plays a pivotal role in providing specialized medical services under a structured franchise model. The firm maintains a market capitalization of $125.02M and employs a workforce of 202 individuals to support its clinical and administrative operations. With annual revenue reaching $54.90M, the company's financial scale suggests a mid-cap position within the healthcare services landscape, indicating a significant but not dominant market presence relative to larger integrated healthcare systems.

Financial Health

The company reported revenue of $54.90M over the trailing twelve months, while net income stood at -$268,157 and EBITDA reached $738,683. The substantial gap between the positive EBITDA of $738,683 and the negative net income of -$268,157 reveals a significant cost structure burdened by non-operating expenses or interest costs that erode bottom-line profitability despite strong operational cash generation. Free cash flow is reported at $5.97M, which indicates that the business retains sufficient liquidity to fund operations, pay down debt, or potentially pursue internal growth initiatives without relying heavily on external capital markets. The company's gross margin is 79.6%, reflecting high pricing power or low cost of goods relative to sales, while the operating margin of 4.2% and profit margin of 5.3% suggest that overhead expenses and other costs consume a considerable portion of the top-line revenue. In terms of liquidity and leverage, total cash holdings of $23.60M far exceed total debt obligations of $2.01M, and the debt-to-equity ratio of 13.33 implies a balance sheet that is heavily leveraged relative to equity, though the absolute debt load remains low against available cash. The current ratio stands at 1.59, indicating that the company holds 1.59 times more current assets than current liabilities, which signals a comfortable position regarding short-term liquidity obligations. Finally, the return on equity is -1.5% and the return on assets is -0.8%, metrics that reveal that management has currently failed to generate positive returns on the capital invested in the business, a situation often observed in growth-stage companies or those with significant one-time charges.

Valuation Assessment

The valuation metrics show a trailing P/E ratio that is listed as N/A due to negative earnings, while the forward P/E is 37.38, a divergence that implies market expectations for future earnings to be significantly higher than current levels to justify the stock price. The price-to-book ratio is 7.90, indicating that the market values the company at nearly eight times its net asset value, which suggests a substantial market premium over the underlying book value of the firm. Alternative valuation metrics further contextualize the stock's pricing, with a price-to-sales ratio of 2.28 and an EV/EBITDA of 131.50, figures that suggest the market is willing to pay a high multiple for revenue and operating cash flow, likely betting on future expansion or margin improvement. The stock has traded between a 52-week low of $7.50 and a 52-week high of $13.47, meaning the current price sits at a level that reflects recent volatility but remains below the recent peak performance. The beta value is 1.28, which explains that the stock price is expected to be 28% more volatile than the broader market, presenting higher risk and potentially higher reward characteristics for price-sensitive investors.

Growth & Income

Revenue growth year-over-year is 3.1%, while earnings growth year-over-year is listed as 6276.7%, a massive discrepancy where earnings are growing significantly faster than revenue due to the normalization of losses or non-recurring item adjustments. Since the company does not pay dividends, the dividend yield is N/A and the payout ratio is 0.0%, indicating that the firm currently reinvests all available earnings or cash flow back into the business rather than distributing income to shareholders. The overall growth and income profile is characterized by strong operational cash flow and a complete absence of dividend payouts, positioning the company as a pure play on operational expansion and future profitability rather than current income generation.

Peer Comparison

The Joint Corp. (JYNT) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
The Joint Corp. JYNT $131.43M 102.4
HCA Healthcare, Inc. HCA $87.05B 13.5
Tenet Healthcare Corporation THC $15.19B 9.2
DaVita Inc. DVA $12.55B 18.8

The Medical Care Facilities industry average P/E ratio is 28.6x. The Joint Corp. trades at a P/E of 102.4.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About The Joint Corp.

The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Visit website →

Key Statistics

Market Cap
$131.43M
P/E Ratio
102.44
52-Week High
$13.47
52-Week Low
$7.50
Avg Volume
68.89K
Beta
1.11

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
United States
Employees
202